SEKINE Ikuo
- Articles
- 抗悪性腫瘍薬の副作用とその対策．腎障害
関根 郁夫
日本臨床/72(増刊号2)/pp.555-559, 2014-02 - III期非小細胞肺がんに対する化学放射線療法の進歩と展望、
関根 郁夫
腫瘍内科/１３(1)/pp.52-58, 2014-01 - 高齢がん患者の臨床的特徴と機能評価
関根 郁夫
臨床血液/55(5)/pp.518-525, 2014-05 - わが国における肺癌の動向／CT検診の現状と今後の展望
関根 郁夫
The LUNG perspectives/23(1)/pp.15-18, 2015-02 - 心音・心雑音のスクリーニング
関根 郁夫
千葉医学雑誌/90(4)/pp.155-157, 2014-08 - 科学論文における英語の話
関根 郁夫
千葉医学雑誌/90(5)/pp.195-200, 2014-10 - 英語論文を読むことと書くこと
関根 郁夫
千葉医学雑誌/90(6)/pp.251-258, 2014-12 - 出来る内科医とは－分野別内科学の観点から
関根 郁夫
千葉医学雑誌/91(2)/pp.87-93, 2015-04 - EGFR-TKIとbevacizumabの併用は一般臨床で使用すべきか?
関根 郁夫
腫瘍内科/15(1)/pp.151-154, 2015-01 - Randomized Pharmacokinetic and Pharmacodynamic Study of Docetaxel: Dosing Based on Body-Surface Area Compared With Individualized Dosing Based on Cytochrome P450 Activity Estimated Using a Urinary Metabolite of Exogenous Cortisol
Sekine Ikuo
J Clin Oncol/23(6)/pp.1061-1069, 2005-01 - Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy
Sekine Ikuo
Lung Cancer/49(2)/pp.217-223, 2005-03 - Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer
Sekine Ikuo
J Clin Oncol/23(28)/pp.6829-6837, 2005-10 - Geographic variation in the second-line treatment of non-small cell lung cancer
Sekine Ikuo
Semin Oncol/33(1 Suppl 1)/pp.S39-S44, 2006-06 - Small-cell lung cancer with hilar and mediastinal lymphadenopathy in an 18-year-old female
Sekine Ikuo
Nat Clin Pract Oncol/3(7)/pp.399-403, 2006-07 - Pharmacokinetics and Pharmacodynamics of Weekly Epoetin Beta in Lung Cancer Patients
Sekine Ikuo
Jpn J Clin Oncol/36(8)/pp.477-482, 2006-08 - Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecan
Sekine Ikuo
Jpn J Clin Oncol/37(5)/pp.358-364, 2007-05 - Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung.
Sekine Ikuo
Jpn J Clin Oncol/37(7)/pp.482-486, 2007-07 - Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years of age or older
Sekine Ikuo
Jpn J Clin Oncol/37(3)/pp.181-185, 2007-04 - Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib
Sekine Ikuo
Clin Cancer Res/13(18 Pt 1)/pp.5385-5390, 2007-09 - Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
Sekine Ikuo
Drug Metab Pharmacokinet/22(6)/pp.462-467, 2007-12 - Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer
Sekine Ikuo
Clin Cancer Res/14(15)/pp.4751-4757, 2008-08 - Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients
Sekine Ikuo
J Thorac Oncol/3(4)/pp.412-416, 2008-04 - EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan.
Sekine Ikuo
J Clin Oncol/26(34)/pp.5589-5595, 2008-09 - Gender differences in treatment outcomes among patients with non-small cell lung cancer given a combination of carboplatin and paclitaxel
Sekine Ikuo
Oncology/75(3-4)/pp.169-174, 2008-10 - Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.
Sekine Ikuo
Radiother Oncol/91(3)/pp.433-437, 2009-06 - more...
- 抗悪性腫瘍薬の副作用とその対策．腎障害